Altered DNA Methylation in Leukocytes with Trisomy 21

English version České info

The primary abnormality in Down syndrome (DS), trisomy 21, is well known; but how this chromosomal gain produces the complex DS phenotype, including immune system defects, is not well understood. We profiled DNA methylation in total peripheral blood leukocytes (PBL) and T-lymphocytes from adults with DS and normal controls and found gene-specific abnormalities of CpG methylation in DS, with many of the differentially methylated genes having known or predicted roles in lymphocyte development and function. Validation of the microarray data by bisulfite sequencing and methylation-sensitive Pyrosequencing (MS-Pyroseq) confirmed strong differences in methylation (p<0.0001) for each of 8 genes tested: TMEM131, TCF7, CD3Z/CD247, SH3BP2, EIF4E, PLD6, SUMO3, and CPT1B, in DS versus control PBL. In addition, we validated differential methylation of NOD2/CARD15 by bisulfite sequencing in DS versus control T-cells. The differentially methylated genes were found on various autosomes, with no enrichment on chromosome 21. Differences in methylation were generally stable in a given individual, remained significant after adjusting for age, and were not due to altered cell counts. Some but not all of the differentially methylated genes showed different mean mRNA expression in DS versus control PBL; and the altered expression of 5 of these genes, TMEM131, TCF7, CD3Z, NOD2, and NPDC1, was recapitulated by exposing normal lymphocytes to the demethylating drug 5-aza-2′deoxycytidine (5aza-dC) plus mitogens. We conclude that altered gene-specific DNA methylation is a recurrent and functionally relevant downstream response to trisomy 21 in human cells.

Vyšlo v časopise: Altered DNA Methylation in Leukocytes with Trisomy 21. PLoS Genet 6(11): e32767. doi:10.1371/journal.pgen.1001212
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001212

Souhrn

Zdroje

1. LejeuneJ

GautierM

TurpinR

1959 Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 248 1721 1722

2. LejeuneJ

TurpinR

GautierM

1959 Mongolism; a chromosomal disease (trisomy). Bull Acad Natl Med 143 256 265

3. WisemanFK

AlfordKA

TybulewiczVL

FisherEM

2009 Down syndrome—recent progress and future prospects. Hum Mol Genet 18 R75 83

4. AntonarakisSE

EpsteinCJ

2006 The challenge of Down syndrome. Trends Mol Med 12 473 479

5. NespoliL

BurgioGR

UgazioAG

MaccarioR

1993 Immunological features of Down's syndrome: a review. J Intellect Disabil Res 37 Pt 6 543 551

6. KarlssonB

GustafssonJ

HedovG

IvarssonSA

AnnerenG

1998 Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79 242 245

7. Du VivierA

MunroDD

1975 Alopecia areata, autoimmunity, and Down's syndrome. Br Med J 1 191 192

8. GillespieKM

DixRJ

WilliamsAJ

NewtonR

RobinsonZF

2006 Islet autoimmunity in children with Down's syndrome. Diabetes 55 3185 3188

9. BookL

HartA

BlackJ

FeoloM

ZoneJJ

2001 Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet 98 70 74

10. WachtelTJ

PueschelSM

1991 Macrocytosis in Down syndrome. Am J Ment Retard 95 417 420

11. RozovskiU

Jonish-GrossmanA

Bar-ShiraA

OchshornY

GoldsteinM

2007 Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod 22 2538 2545

12. PrandiniP

DeutschS

LyleR

GagnebinM

Delucinge VivierC

2007 Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 81 252 263

13. LiCM

GuoM

SalasM

SchupfN

SilvermanW

2006 Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 7 24

14. MaoR

WangX

SpitznagelELJr

FrelinLP

TingJC

2005 Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol 6 R107

15. GiannoneS

StrippoliP

VitaleL

CasadeiR

CanaiderS

2004 Gene expression profile analysis in human T lymphocytes from patients with Down Syndrome. Ann Hum Genet 68 546 554

16. KerkelK

SpadolaA

YuanE

KosekJ

JiangL

2008 Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 40 904 908

17. IssaJP

2003 Age-related epigenetic changes and the immune system. Clin Immunol 109 103 108

18. de HinghYC

van der VossenPW

GemenEF

MulderAB

HopWC

2005 Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr 147 744 747

19. MaccarioR

UgazioAG

NespoliL

AlberiniC

MontagnaD

1984 Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells. Clin Exp Immunol 57 220 226

20. AnnerenG

MagnussonCG

LiljaG

NordvallSL

1992 Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child 67 628 631

21. LohRK

HarthSC

ThongYH

FerranteA

1990 Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J 9 547 551

22. CossarizzaA

OrtolaniC

FortiE

MontagnaniG

PaganelliR

1991 Age-related expansion of functionally inefficienT-cells with markers of natural killer activity in Down's syndrome. Blood 77 1263 1270

23. NobleRL

WarrenRP

1988 Analysis of blood cell populations, plasma zinc and natural killer cell activity in young children with Down's syndrome. J Ment Defic Res 32 Pt 3 193 201

24. MahmoudSA

Lowery-NordbergM

ChenH

ThurmonT

UrsinS

2005 Immune defects in subjects with dysmorphic disorders. Allergy Asthma Proc 26 373 381

25. NurmiT

HuttunenK

LassilaO

HenttonenM

SakkinenA

1982 Natural killer cell function in trisomy-21 (Down's syndrome). Clin Exp Immunol 47 735 741

26. HannaJ

BechtelP

ZhaiY

YoussefF

McLachlanK

2004 Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 173 6547 6563

27. TybulewiczVL

FisherEM

2006 New techniques to understand chromosome dosage: mouse models of aneuploidy. Hum Mol Genet 15 Spec No 2 R103 109

28. ChangoA

Abdennebi-NajarL

TessierF

FerreS

DoS

2006 Quantitative methylation-sensitive arbitrarily primed PCR method to determine differential genomic DNA methylation in Down Syndrome. Biochem Biophys Res Commun 349 492 496

29. JenkinsEC

SchupfN

GenoveseM

YeLL

KapellD

1997 Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome. Am J Med Genet 68 147 151

30. PercyME

MarkovicVD

DaltonAJ

McLachlanDR

BergJM

1993 Age-associated chromosome 21 loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease. Am J Med Genet 45 584 588

31. WilsonMG

TownerJW

ForsmanI

1980 Decreasing mosaicism in Down's syndrome. Clin Genet 17 335 340

32. JablonskaB

FordD

TrislerD

PessacB

2006 The growth capacity of bone marrow CD34 positive cells in culture is drastically reduced in a murine model of Down syndrome. C R Biol 329 726 732

33. CarmichaelCL

MajewskiIJ

AlexanderWS

MetcalfD

HiltonDJ

2009 Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood 113 1929 1937

34. AlfordK

SlenderA

VanesL

LiZ

FisherEM

Perturbed hematopoiesis in the Tc1 mouse model of Down Syndrome. Blood

35. TydellCC

David-FungES

MooreJE

RowenL

TaghonT

2007 Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway. J Immunol 179 421 438

36. HeldW

KunzB

Lowin-KropfB

van de WeteringM

CleversH

1999 Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 11 433 442

37. KunzB

HeldW

2001 Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells. J Immunol 166 6181 6187

38. IoannidisV

KunzB

TanamachiDM

ScarpellinoL

HeldW

2003 Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1. J Immunol 171 769 775

39. GuoY

MaillardI

ChakrabortiS

RothenbergEV

SpeckNA

2008 Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification. Blood 112 480 492

40. RahmanMK

MidtlingEH

SvingenPA

XiongY

BellMP

TungJ

SmyrkT

EganLJ

FaubionWAJr

2010 The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J Immunol 184 7247 7256

41. ChenG

DimitriouID

La RoseJ

IlangumaranS

YehWC

DoodyG

TurnerM

GommermanJ

RottapelR

2007 The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response. Mol Cell Biol 8 3109 3122

42. MorA

CampiG

DuG

ZhengY

FosterDA

2007 The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol 9 713 719

43. MaoX

GreenJM

SaferB

LindstenT

FredericksonRM

1992 Regulation of translation initiation factor gene expression during human T cell activation. J Biol Chem 267 20444 20450

44. MurookaTT

RahbarR

PlataniasLC

FishEN

2008 CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood 111 4892 4901

45. DobrevaG

DambacherJ

GrosschedlR

2003 SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17 3048 3061

46. TeruiY

SaadN

JiaS

McKeonF

YuanJ

2004 Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J Biol Chem 279 28257 28265

47. GaraudeJ

FarrasR

BossisG

CharniS

PiechaczykM

2008 SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J Immunol 180 5983 5990

48. EvrardC

CaronS

RougetP

2004 Functional analysis of the NPDC-1 gene. Gene 343 153 163

49. JiangL

GondaT

GambleM

SalasM

SeshanV

2008 Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 68 9900 9908

50. YuanE

HaghighiF

WhiteS

CostaR

McMinnJ

2006 A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons. Cancer Res 66 3443 3451

51. LinM

WeiLJ

SellersWR

LieberfarbM

WongWH

2004 dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20 1233 1240

52. LiLC

DahiyaR

2002 MethPrimer: designing primers for methylation PCRs. Bioinformatics 18 1427 1431

53. LivakKJ

SchmittgenTD

2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 408